Effect of Diacerein on Metabolic Control and Inflammatory Markers in Patients with Type 2 Diabetes Using Antidiabetic Agents: A Randomized Controlled Trial

Effect of diacerein on renal function and inflammatory cytokines in participants with type 2 diabetes mellitus and chronic kidney disease: A randomized controlled trial

(2017) Fabiana Piovesan et al.   PLoS One

Effect of diacerein as an add-on to metformin in patients with type 2 diabetes mellitus and inadequate glycemic control

(2017) Miriam Méndez-del Villar et al.   Archives of Endocrinology Metabolism

Antidiabetic agents: Potential anti-inflammatory activity beyond glucose control

(2015) A.J. Scheen et al.   DIABETES & METABOLISM

Inflammation as a link between obesity, metabolic syndrome and type 2 diabetes

(2014) Nathalie Esser et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

Anti-inflammatory agents to treat or prevent type 2 diabetes, metabolic syndrome and cardiovascular disease

(2014) Nathalie Esser et al.   EXPERT OPINION ON INVESTIGATIONAL DRUGS

Inflammatory Markers and Risk of Type 2 Diabetes: A systematic review and meta-analysis

(2012) X. Wang et al.   DIABETES CARE

Effect of Diacerein on Insulin Secretion and Metabolic Control in Drug-Naive Patients With Type 2 Diabetes: A randomized clinical trial

(2011) M. G. Ramos-Zavala et al.   DIABETES CARE

Diacerhein Improves Glucose Tolerance and Insulin Sensitivity in Mice on a High-Fat Diet

(2011) Natália Tobar et al.   ENDOCRINOLOGY

Adipose Tissue, Inflammation and Atherosclerosis

(2011) Birgit Gustafson   Journal of Atherosclerosis and Thrombosis

Diacerhein downregulate proinflammatory cytokines expression and decrease the autoimmune diabetes frequency in nonobese diabetic (NOD) mice

(2008) Carina Malaguti et al.   INTERNATIONAL IMMUNOPHARMACOLOGY